Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Neoplasms|Breast Neoplasm Female|Breast Cancer Female|HER2-negative Breast Cancer|Hormone Receptor-positive Breast Cancer|Advanced Breast Cancer
Interventions: DRUG: Ribociclib
Sponsor: Institut fuer Frauengesundheit
Collaborators: AGO Breast Study Group e.V.|Novartis Pharmaceuticals